These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30132244)

  • 1. Antithrombotic therapy after mitral valve repair: VKA or aspirin?
    van der Wall SJ; Olsthoorn JR; Heuts S; Klautz RJM; Tomsic A; Jansen EK; Vonk ABA; Sardari Nia P; Klok FA; Huisman MV
    J Thromb Thrombolysis; 2018 Nov; 46(4):473-481. PubMed ID: 30132244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Whitlock RP; Sun JC; Fremes SE; Rubens FD; Teoh KH
    Chest; 2012 Feb; 141(2 Suppl):e576S-e600S. PubMed ID: 22315272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.
    Paparella D; Di Mauro M; Bitton Worms K; Bolotin G; Russo C; Trunfio S; Scrofani R; Antona C; Actis Dato G; Casabona R; Colli A; Gerosa G; Renzulli A; Serraino F; Scrascia G; Zaccaria S; De Bonis M; Taramasso M; Delgado L; Tritto F; Marmo J; Parolari A; Myaseodova V; Villa E; Troise G; Nicolini F; Gherli T; Whitlock R; Conte M; Barili F; Gelsomino S; Lorusso R; Sciatti E; Marinelli D; Di Giammarco G; Calafiore AM; Sheikh A; Alfonso JJ; Glauber M; Miceli A;
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1302-8.e1. PubMed ID: 26832208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
    van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic events early after mitral valve repair: incidence and predictive factors.
    Meurin P; Tabet JY; Iliou MC; Pierre B; Corone S; Cristofini P; Iung B; Ben Driss A;
    Int J Cardiol; 2008 May; 126(1):45-52. PubMed ID: 17490763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of major bleeding events on aspirin versus vitamin K antagonists in randomized trials.
    Ambrosi P; Daumas A; Villani P; Giorgi R
    Int J Cardiol; 2017 Mar; 230():572-576. PubMed ID: 28063671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
    Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of complications of antithrombotic treatment in patients with atrial fibrillation].
    Novaković Anucin S; Gnip S; Canak V; Radović P; Kovacev J; Mitić G
    Med Pregl; 2013; 66(11-12):470-5. PubMed ID: 24575635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the antithrombotic strategy in low thrombotic risk patients who underwent aortic valve replacement with a bioprosthesis].
    Aceves-Velázquez E; Vieyra-Herrera G; Rodríguez-Chávez L; Herrera-Alarcón V
    Arch Cardiol Mex; 2018 Dec; 88(5):339-346. PubMed ID: 28720315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
    Olesen JB; Lip GY; Lindhardsen J; Lane DA; Ahlehoff O; Hansen ML; Raunsø J; Tolstrup JS; Hansen PR; Gislason GH; Torp-Pedersen C
    Thromb Haemost; 2011 Oct; 106(4):739-49. PubMed ID: 21789337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis.
    Vazquez FJ; Gonzalez JP; LeGal G; Carrier M; Gándara E
    Thromb Res; 2016 Feb; 138():1-6. PubMed ID: 26826501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
    Zhang H; Dong Y; Ao X; Fu B; Dong L;
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis.
    Vink R; Kraaijenhagen RA; Hutten BA; van den Brink RB; de Mol BA; Büller HR; Levi M
    J Am Coll Cardiol; 2003 Dec; 42(12):2042-8. PubMed ID: 14680724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Salem DN; O'Gara PT; Madias C; Pauker SG
    Chest; 2008 Jun; 133(6 Suppl):593S-629S. PubMed ID: 18574274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
    Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
    Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
    Garcia DA; Wallentin L; Lopes RD; Thomas L; Alexander JH; Hylek EM; Ansell J; Hanna M; Lanas F; Flaker G; Commerford P; Xavier D; Vinereanu D; Yang H; Granger CB
    Am Heart J; 2013 Sep; 166(3):549-58. PubMed ID: 24016506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.